Ribociclib Succinate

Cat. No.: PI1374639754

Description: Ribociclib succinate is a type of cyclin-dependent kinase inhibitor. It was developed by Novartis and Astex Pharmaceuticals. It is used to treat hormone-receptor positive (HR+), HER2 negative (HER2-) breast cancer that is advanced or has spread to other parts of the body.

Product Details

CAS	1374639-75-4
Trade Names	Kisqali
Synonyms	7-Cyclopentyl-N,N-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide succinate
Molecular Formula	C27H36N8O5
Molecular Weight	552.6
Available Formulations	Oral Solid
Technology	Synthetic
Available DMF/CEP/GMP	US DMF

* Our products are for research use only.

Get in Touch

We’re glad to help you with your products and services demands. For any inquiry, question or recommendation, please send an email to or fill out the following form.

Name *

Phone

Email *

Address *

Products & Service of Interest *

Project Description

Verification Code *